| 000 | 01629 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517021745.0 | ||
| 264 | 0 | _c20160120 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a2158-3188 | ||
| 024 | 7 |
_a10.1038/tp.2014.147 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStansfield, K H | |
| 245 | 0 | 0 |
_aEarly-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia. _h[electronic resource] |
| 260 |
_bTranslational psychiatry _cMar 2015 |
||
| 300 |
_ae522 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aDopamine _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHyperkinesis _xblood |
| 650 | 0 | 4 |
_aInterneurons _xmetabolism |
| 650 | 0 | 4 |
_aLead _xadverse effects |
| 650 | 0 | 4 |
_aLead Poisoning _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aParvalbumins _xblood |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPrenatal Exposure Delayed Effects _xblood |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Long-Evans |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSchizophrenia _xblood |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xblood |
| 700 | 1 | _aRuby, K N | |
| 700 | 1 | _aSoares, B D | |
| 700 | 1 | _aMcGlothan, J L | |
| 700 | 1 | _aLiu, X | |
| 700 | 1 | _aGuilarte, T R | |
| 773 | 0 |
_tTranslational psychiatry _gvol. 5 _gp. e522 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/tp.2014.147 _zAvailable from publisher's website |
| 999 |
_c24694143 _d24694143 |
||